Urocortin, a novel neuropeptide with anxiogenic-like properties

NeuroReport

Volumn 8, Issue 7, 1997, Pages 1697-1701

  Moreau, Jean Luc ^a   Kilpatrick, Gavin ^a   Jenck, François ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Anxiety; Corticotropin releasing factor (CRF); CRF2; receptor; Stress; Urocortin

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY NEUROSIS; ARTICLE; DOSE RESPONSE; LIGHT DARK CYCLE; MALE; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 0030897376     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199705060-00027     Document Type: Article

References (28)

1. Grigoriadis DE, Lovenberg TW, Chalmers DT et al. Ann NY Acad Sci 780, 60-80 (1996).
2. Heinrichs SC, Menzaghi F, Merlo-Pich E et al. Ann NY Acad Sci 780, 93-104 (1996).
3. Sutton R, Koob G, Le Moal M et al. Nature 297, 331-333 (1982).
4. Sherman JE and Kalin NH. Pharmacol Biochem Behav 26, 699-703 (1987).
5. Dunn AJ and Berridge CW. Brain Res 15, 71-100 (1990).
6. Koob GF, Heinrichs SC, Merlo Pich E et al. The role of corticotropin-releasing factor in behavioral responses to stress. In: De Souza EB and Nemeroff CB, eds Corticotropin-releasing Factor: Basic and Clinical Studies of a Neuropeptide. Boca Raton: CRC Press, 1993: 277-295.
7. Britton DR, Koob GF, Rivier J et al. Life Sci 31, 363-367 (1982).
8. Britton KT, Morgan J, Rivier W et al. Psychopharmacology 86, 170-174 (1985).
9. Swerdlow NR, Geyer MA, Vale WW et al. Psychopharmacology 88, 147-152 (1986).
10. Dunn AJ and File SE. Horm Beav 21, 193-202 (1987).
11. Cole BJ and Koob GF. J Pharmacol Exp Ther 247, 902-910 (1988).
12. Sarnyai Z, Biro E, Gardi J et al. Brain Res 675, 89-97 (1995).
13. Baldwin HA, Rassnick S, Rivier J et al. Psychopharmacology 103, 227-232 (1991).
14. Rassnick S, Heinrichs SC, Britton KT et al. Brain Res 605, 25-32 (1993).
15. Heinrichs SC, Menzaghi F, Merlo Pich E, et al. Neuropsychopharmacology 11, 179-186 (1994).
16. Stenzel Poore MP, Heinrichs SC, Rivest S et al. J Neurosci 14, 2579-2584 (1994).
17. Skutella T, Criswell H, Moy S et al. NeuroReport 5, 2181-2185 (1994).
18. Vaughan J, Donaldson C, Bittencourt W et al. Nature 387, 287-292 (1995).
19. Spina MR. Merlo-Pich E, Chan RKW et al. Science 273, 1561-1564 (1996).
20. Clark WG, Vivonia CA and Baxter CF. J Appl Physiol 25, 319-321 (1968).
21. Pellow S and File SE. Pharmacol Biochem Behav 24, 525-529 (1986).
22. Jones DNC, Kortekaas R, Slade PD et al. Br J Pharmacol P227 (1996).
23. Lister RG. Pharmacol Ther 46, 321-340 (1990).
24. File SE and Lister RG. Neuropharmacology 21, 1215-1218 (1982).
25. Lister RG. Life Sci 41, 1481-1489 (1987).
26. Donaldson CJ, Sutton SW, Perrin MH et al. Endocrinol 137, 2167-2170 (1996).
27. Grigoriadis DE, Liu X-J, Vaughn J et al. Mol Pharmacol 50, 679-686 (1996).
28. Kishimoto T, Pearse RV, Lin CR et al. Proc Natl Acad Sci 92, 1108-1112 (1995).